Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Characteristics of ovarian cancer patients, N = 12,835.

From: Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study

  Ovarian cancer without VTE Ovarian cancer less than 4 months after VTE Ovarian cancer 4 months to 27 years after VTE
  (N = 12,707) (N = 50) (N = 78)
Median age, years 63 67 71
(25%–75% percentile) (54–73) (58–78) (62–78)
Age groups    
<50 years 2,239 (18%) 6 (12%) 9 (12%)
50–69 years 6,328 (50%) 22 (44%) 28 (36%)
70–89 years 4,051 (32%) 22 (44%) 39 (50%)
90+ years 89 (1%) 0 (0%) 2 (3%)
Year of diagnosis    
1980–84 2,538 (20%) 10 (20%) 4 (5%)
1985–89 2,711 (21%) 13 (26%) 13 (17%)
1990–94 2,671 (21%) 7 (14%) 20 (26%)
1995–99 2,690 (21%) 7 (14%) 24 (31%)
2000–03 2,097 (17%) 13 (26%) 17 (22%)
Comorbidity a    
0 11,289 (89%) 47 (94%) 60 (77%)
1–2 1,361 (11%) 3 (6%) 17 (22%)
3+ 57 (<1%) 0 1 (1%)
  1. a Charlson Comorbidity Index